title: Phlorizin-induced normoglycemia partially restores glucoregulation in diabetic dogs.
abstract: The plasma concentration of glucagon (IRG), catecholamines, and hepatic glucose production (Ra) were followed in insulin-induced hypoglycemia in dogs before (normal) and at 14-21 and again at 89-119 days after the injection of alloxan (diabetic). Some diabetic dogs were also tested when euglycemia was restored by phlorizin. In the normal state plasma IRG and epinephrine were raised by a factor of 3 and 15, respectively. Ra increased in two phases, an early peak (350% basal) was followed by a plataeu at about twice basal. In diabetes, irrespective of its duration, plasma IRG was decreased in hypoglycemia, and the rise in plasma epinephrine was significantly reduced. Ra remained unchanged. In phlorizin-treated euglycemic diabetic dogs plasma IRG fell, and the response in plasma epinephrine remained blunted. There was no early rise in Ra, but the same elevated plateau was reached at the same time as in normal animals. In conclusion, the following is observed in diabetic dogs. 1) The sensitivity of alpha-cells to insulin is maintained, but that to hypoglycemia is lost. The concentration of plasma catecholamines is raised less than in normals. With no increase in plasma glucagon this rise is not sufficient to increase Ra. 2) Restoration of euglycemia with phlorizin does not restore normal IRG and epinephrine responses to hypoglycemia but restores the delayed increase of Ra. Thus the restoration of euglycemia in severely diabetic dogs partially restores the responses of the liver, but not of the alpha-cell or sympathetic discharge, to hypoglycemia.
authors.affiliation: Department of Physiology, School of Medicine, University of Ottawa, Toronto, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Hetenyi
authors.forename: C
authors.initials: C
authors.lastname: Gauthier
authors.forename: M
authors.initials: M
authors.lastname: Byers
authors.forename: M
authors.initials: M
authors.lastname: Vranic
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000097:blood*; D004285:Dogs; D004298:Dopamine / Q000097:blood; D004837:Epinephrine / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood; D006706:Homeostasis; D007328:Insulin / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009638:Norepinephrine / Q000097:blood; D010695:Phlorhizin / Q000494:pharmacology*; D012016:Reference Values
chemical_list: D001786:Blood Glucose; D007328:Insulin; D005934:Glucagon; D010695:Phlorhizin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine